FDA Approved: VARUBI — Original Application (TerSera Therapeutics LLC)

View source ↗

Summary

Varubi (rolapitant) received FDA approval as an antiemetic to prevent chemotherapy-induced nausea and vomiting in adults undergoing initial or repeated courses …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• VARUBI (rolapitant)

Snippet

ORIG AP for VARUBI (ROLAPITANT)